(Q44719893)

5 December 2017

Resting metabolic rate in severely obese diabetic and nondiabetic subjects (English)

1 reference

5 December 2017

0 references

Kuo-Chin Huang

1

1 reference

5 December 2017

Nic Kormas

2

1 reference

5 December 2017

Katharine Steinbeck

3

1 reference

5 December 2017

Georgina Loughnan

4

1 reference

5 December 2017

Ian D Caterson

5

1 reference

5 December 2017

1 May 2004

1 reference

5 December 2017

1 reference

5 December 2017

12

1 reference

5 December 2017

840-845

1 reference

5 December 2017

5

1 reference

Prevalence and Trends in Obesity Among US Adults, 1999-2000

5 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Reduced rate of energy expenditure as a risk factor for body-weight gain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Resting energy expenditure in the obese: a cross-validation and comparison of prediction equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

The Harris-Benedict studies of human basal metabolism: history and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

The theoretical bases of indirect calorimetry: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Effect of impaired glucose tolerance and type II diabetes on resting metabolic rate and thermic response to a glucose meal in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Effect of NIDDM on the kinetics of whole-body protein metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Obesity as a medical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Four anthropometric indices and cardiovascular risk factors in Taiwan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

A compilation of total daily energy expenditures and body weights in healthy adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Predicting basal metabolic rate in the obese is difficult

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Resting energy expenditure in diabetic and nondiabetic patients with liver cirrhosis: relation with insulin sensitivity and effect of liver transplantation and immunosuppressive therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Prediction of resting energy expenditure from fat-free mass and fat mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Determinants of resting energy expenditure in obese non-diabetic caucasian women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

A new predictive equation for resting energy expenditure in healthy individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

Increased energy expenditure in poorly controlled Type 1 (insulin-dependent) diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

The prediction of resting energy expenditure in type 2 diabetes mellitus is improved by factoring for glycemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.101

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.101

1 reference

5 December 2017

1 reference